15-334
Showing 1 - 25 of >10,000
Migraine Trial in Worldwide (Erenumab Dose 1, Erenumab Dose 2, Erenumab Dose 3)
Recruiting
- Migraine
- Erenumab Dose 1
- +3 more
-
Aurora, Colorado
- +88 more
Feb 1, 2023
Episodic Migraine Trial in Worldwide (AMG334 (70 mg) Pre-Filled Syringe (PFS), Placebo Pre-Filled Syringe (PFS))
Completed
- Episodic Migraine
- AMG334 (70 mg) Pre-Filled Syringe (PFS)
- Placebo Pre-Filled Syringe (PFS)
-
Heidelberg, Australia
- +58 more
Feb 23, 2022
Migraine Trial in United States (AMG 334 Dose 1, AMG 334 Dose 2, AMG 334 Dose 3)
Terminated
- Migraine
- AMG 334 Dose 1
- +2 more
-
Little Rock, Arkansas
- +13 more
Feb 10, 2022
Acne Vulgaris Trial in Worldwide (CB-03-01 cream, 1%, Vehicle cream)
Completed
- Acne Vulgaris
- CB-03-01 cream, 1%
- Vehicle cream
-
Scottsdale, Arizona
- +51 more
Oct 29, 2020
Breast Cancer, Aromatase Inhibitors Trial in Montpellier, Nîmes (Whole-body cryotherapy, Placebo cryotherapy)
Not yet recruiting
- Breast Cancer
- Aromatase Inhibitors
- Whole-body cryotherapy
- Placebo cryotherapy
-
Montpellier, France
- +1 more
Jul 28, 2022
Tattoo; Pigmentation, Cancer, Treatment-Related Trial in Detroit (Semi-Permanent Tattoo Ink)
Recruiting
- Tattoo; Pigmentation
- Cancer, Treatment-Related
- Semi-Permanent Tattoo Ink
-
Detroit, MichiganHenry Ford Health System
Jul 20, 2022
Pneumococcal Vaccines Trial in United States (0.5 ml dose of 1.1 mcg VAX-24, 0.5 ml dose of PCV15, 0.5 ml dose of 2.2 mcg
Recruiting
- Pneumococcal Vaccines
- 0.5 ml dose of 1.1 mcg VAX-24
- +3 more
-
Jonesboro, Arkansas
- +25 more
May 4, 2023
Non Small Cell Lung Cancer NSCLC Trial in Worldwide (Durvalumab, Tremelimumab, Abraxane + carboplatin)
Recruiting
- Non Small Cell Lung Cancer NSCLC
- Durvalumab
- +6 more
-
Phoenix, Arizona
- +181 more
Aug 17, 2022
Atrial Fibrillation, Deep Vein Thrombosis, Stroke Trial in France (Weekly monitoring using the capillary International
Recruiting
- Atrial Fibrillation
- +2 more
- Weekly monitoring using the capillary International Normalised Ratio strategy
-
Aigues-mortes, Gard, France
- +32 more
Nov 22, 2022
Squamous NSCLC Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (anti-PD-L1) antibody,
Completed
- Squamous Non-Small Cell Lung Cancer
- Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (anti-PD-L1) antibody
- +3 more
-
Chandler, Arizona
- +241 more
Mar 17, 2022
Atlantoaxial Dislocation Trial (Intra-articular Cages)
Not yet recruiting
- Atlantoaxial Dislocation
- Intra-articular Cages
- (no location specified)
Aug 20, 2023
for Surgical Treatment of Irreducible Atlantoaxial Dislocation
Not yet recruiting
- Atlantoaxial Dislocation
- Posterior intra-articular distraction and fusion
- +2 more
- (no location specified)
Jul 30, 2023
Acute Bacterial Skin and Skin Structure Infections Trial in Worldwide (ceftobiprole medocaril, vancomycin+aztreonam)
Completed
- Acute Bacterial Skin and Skin Structure Infections
- ceftobiprole medocaril
- vancomycin+aztreonam
-
Anaheim, California
- +33 more
Mar 7, 2022
Advanced Breast Cancer, Metastatic Breast Cancer, Breast Cancer Trial in United States (NUV-422, Fulvestrant)
Recruiting
- Advanced Breast Cancer
- +7 more
-
Anaheim, California
- +4 more
Apr 6, 2022
Perceptions of Their Own Body and of Body of Their Child Among
Not yet recruiting
- Anorexia Nervosa
- Eating Disorders
- BodyBabe questionnaire
-
Clermont-Ferrand, FranceChu Clermont Ferrand
Feb 9, 2022
Reciprocal Benefit by Intergenerational Meetings
Not yet recruiting
- Isolation, Social
- Regular exchanges
-
Nice, FranceInstitut Claude Pompidou
Sep 19, 2022
Frailty Trial in Auburn (Magnetic Mitohormesis Therapy)
Recruiting
- Frailty
- Magnetic Mitohormesis Therapy
-
Auburn, AlabamaAuburn University
Jul 3, 2023